Sign in

CIK 0001446847 · Accelerated filer<br>Smaller reporting company

IRONWOOD PHARMACEUTICALS INC

Sign in to watch
Ticker
IRWD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
043404176
Phone
617-621-7722
Business address
100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110
  1. 4 Grant or award Director acquired 3,282 shares (grant or award)
  2. 4 Open-market sale Chief Legal Officer sold 9,910 shares at $4.27 ($42,316)
  3. 4 Open-market sale Principal Accounting Officer sold 3,107 shares at $4.27 ($13,267)
  4. 4 Grant or award Director acquired 24,311 shares (grant or award)
  5. 4 Grant or award Director acquired 24,311 shares (grant or award)
  6. 4 Grant or award Director acquired 24,311 shares (grant or award)
  7. 4 Grant or award Director acquired 24,311 shares (grant or award)
  8. 4 Grant or award Director acquired 24,311 shares (grant or award)
  9. 4 Grant or award Director acquired 24,311 shares (grant or award)
  10. 4 Grant or award Director acquired 24,311 shares (grant or award)
  11. 4 Grant or award Director acquired 24,311 shares (grant or award)
  12. 4 Grant or award Director acquired 2,572 shares (grant or award)
  13. 4 Planned sale Director sold 22,766 shares at $6.29 ($143,198)
  14. 4 Open-market sale Director sold 80,000 shares at an average $6.47 ($517,694)
  15. 4 Open-market sale Chief Executive Officer sold 67,618 shares at $6.45 ($436,136)
  16. 4 Open-market sale SVP, Chief Business Officer sold 22,725 shares at $6.45 ($146,576)
  17. 4 Open-market sale CMO,SVP,Head-Res&Drug sold 16,128 shares at $6.45 ($104,026)
  18. 4 Open-market sale Chief Legal Officer sold 17,404 shares at $6.45 ($112,256)
  19. 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 18,280 shares (to pay taxes)
  20. 4 Grant or award Director acquired 1,662 shares (grant or award)

Page 4 of 41 · 806 filings